Hologic Announces Martin Madaus as Member of Its Board of Directors
Hologic, Inc. recently announced that Martin Madaus has been elected to the Company’s Board of Directors, effective December 6, 2024. Dr. Madaus was also appointed to the Compensation Committee and the Nominating and Corporate Governance Committee effective December 6, 2024. Dr. Madaus, who has more than 30 years of diagnostics and life sciences industry experience, […]
The Indo US Bridging RARE Summit
The Indo US Bridging RARE Summit, scheduled for Nov 16-18 2024 is based on the theme “Combating Rare Diseases by Fostering Cross-Border Collaborations, Data Sharing, and Clinical Trials” and promises to provide a unique program that will focus on cross-border collaborations and new perspectives from a broad spectrum of stakeholders of rare diseases.This prestigious event […]
VION Biosciences Acquires Echelon Biosciences
VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, announced the recent acquisition of Salt Lake City-based Echelon Biosciences, a trusted supplier of critical materials, notably lipid-based excipients, to its growing portfolio. This acquisition serves as the second investment under VION Biosciences LLC […]
Sirnaomics and Gore Range Capital Partner to Launch Sagesse Bio, an Aesthetic Medicine Company
Sirnaomics Ltd., a leading biopharmaceutical company, and Gore Range Capital LLC have announced a partnership to establish Sagesse Bio, Inc., a joint venture poised to transform the aesthetic medicine industry. Sagesse Bio will harness the power of RNAi therapeutics to develop innovative products for body contouring and fat reduction. The partnership combines Sirnaomics’ expertise in […]
AusperBio secures USD 37Mln in series A financing
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a privately held clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies, with the goal of achieving functional cure for chronic hepatitis B (CHB) infection, yesterday announced the completion of a $37 million Series A financing round. This round was led by existing investor, InnoPinnacle Fund, with participation from new […]
CycleØ announces acquisition of Biogasclean
CycleØ Group Limited today announces its acquisition of Biogasclean, a leading Danish supplier of biological methanation and desulphurisation systems. A prominent, pan-European biomethane platform, CycleØ develops, builds, owns and operates renewable natural gas (RNG) projects in Europe and Latin America. Ara Partners, a private equity and infrastructure investment firm at the forefront of industrial decarbonisation, provided additional […]
CG Life adds Chris Weber as SVP of strategy
CG Life, a leading integrated agency that blends strategic creative, marketing, digital, and communications with science, has welcomed Chris Weber as the agency’s Senior Vice President of Strategy. Weber brings three decades of healthcare agency experience to the role, where he will be responsible for broadening CG Life’s strategic offering and working closely with clients, especially those […]
Bristol Myers Squibb acquires Karuna Therapeutics
Bristol Myers Squibb and Karuna Therapeutics, Inc. recently announced that they have entered into a definitive merger agreement under which Bristol Myers Squibb has agreed to acquire Karuna for $330.00 per share in cash, for a total equity value of $14.0 billion, or $12.7 billion net of estimated cash acquired. The transaction was unanimously approved […]
Ligandal Inc. Appoints Tushar Nuwal for two leadership roles
Ligandal Inc., an early-stage genetic medicine biotechnology company, announces the appointment of Tushar Nuwal as Chief Operating Officer and Chief Business Officer. Mr. Nuwal brings 20 years of biopharmaceutical experience, including roles at small and large pharmaceutical companies. “We are elated to welcome Tushar to Ligandal. His experience in negotiating multi-billion-dollar pharmaceutical transactions and his […]
Massive Bio and CureMatch Partner to provide AI powered cancer treatment
Massive Bio, an AI-powered platform connecting patients with clinical trials and CureMatch, a healthcare technology company leveraging Knowledge Representation & Reasoning (KRR) AI for precision medicine support for oncology, and have announced a transformative partnership aimed at revolutionizing cancer treatment through advanced genomics, artificial intelligence, and expansive clinical trial accessibility. Massive Bio and CureMatch will leverage […]
